Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Mark Robson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Genes & Molecular Sequences
Disorders
Physiology
Chemicals & Drugs
Living Beings
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
44
Offit, Kenneth
19
Norton, Larry
16
Kauff, Noah
15
Hudis, Clifford
13
Borgen, Patrick
13
Boyd, Jeff
11
Barakat, Richard
10
Ellis, Nathan
10
Satagopan, Jaya
9
Nafa, Khedoudja
8
Panageas, Katherine
8
Scheuer, Lauren
6
Hensley, Martee
6
Hurria, Arti
6
D'Andrea, Gabriella
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Mark Robson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kirchhoff Tomas; Chen Zhang-qun; Gold Bert; Pal Prodipto; Gaudet Mia M; Kosarin Kristi; Levine Douglas A; Gregersen Peter; Spencer Sara; Harlan Megan; Robson Mark; Klein Robert J; Hudis Clifford A; Norton Larry; Dean Michael; Offit Kenneth
The 6q22.33 locus and breast cancer susceptibility.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2468-75.
-
2009: Ginsburg Ophira; Ghadirian Parviz; Lubinski Jan; Cybulski Cezary; Lynch Henry; Neuhausen Susan; Kim-Sing Charmaine; Robson Mark; Domchek Susan; Isaacs Claudine; Klijn Jan; Armel Susan; Foulkes William D; Tung Nadine; Moller Pal; Sun Ping; Narod Steven A;
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Breast cancer research and treatment 2009;114(1):127-35.
-
2009: Agarwal Rinki; Robson Mark
Inherited predisposition to gastrointestinal stromal tumor.
Hematology/oncology clinics of North America 2009;23(1):1-13, vii.
-
2009: Berrington de Gonzalez Amy; Berg Christine D; Visvanathan Kala; Robson Mark
Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
Journal of the National Cancer Institute 2009;101(3):205-9.
-
2009: Zon Robin T; Goss Elizabeth; Vogel Victor G; Chlebowski Rowan T; Jatoi Ismail; Robson Mark E; Wollins Dana S; Garber Judy E; Brown Powel; Kramer Barnett S;
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):986-93.
-
2009: Schwartz Gordon F; Hughes Kevin S; Lynch Henry T; Fabian Carol J; Fentiman Ian S; Robson Mark E; Domchek Susan M; Hartmann Lynn C; Holland Roland; Winchester David J; Anderson Benjamin O; Arun Banu K; Bartelink Harry; Bernard Philip; Bonanni Bernardo; Cady Blake; Clough Krishna B; Feig Stephen A; Heywang-Köbrunner Sylvia H; Howell Anthony; Isaacs Claudine; Kopans Daniel B; Mansel Robert E; Masood Shahla; Palazzo Juan P; Pressman Peter I; Solin Lawrence J; Untch Michael
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
The breast journal 2009;15(1):4-16.
-
2009: Ferrone Cristina R; Levine Douglas A; Tang Laura H; Allen Peter J; Jarnagin William; Brennan Murray F; Offit Kenneth; Robson Mark E
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):433-8.
-
2008: Schwartz Gordon F; Hughes Kevin S; Lynch Henry T; Fabian Carol J; Fentiman Ian S; Robson Mark E; Domchek Susan M; Hartmann Lynn C; Holland Roland; Winchester David J;
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
Cancer 2008;113(10):2627-37.
-
2008: Dang Chau; D'Andrea Gabriella; Lake Diana; Sugarman Steve; Fornier Monica; Moynahan Mary Ellen; Gilewski Theresa; Hurria Arti; Mills Nancy; Troso-Sandoval Tiffany; George Roshini; Robson Mark; Dickler Maura; Smith Karen; Panageas Katherine S; Norton Larry; Hudis Clifford A
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.
Clinical breast cancer 2008;8(5):418-24.
-
2008: Traina T A; Poggesi I; Robson M; Asnis A; Duncan B A; Heerdt A; Dang C; Lake D; Moasser M; Panageas K; Borgen P; Norton L; Hudis C; Dickler M N
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.
Breast cancer research and treatment 2008;111(2):377-88.
-
2008: Dang Chau; Fornier Monica; Sugarman Steven; Troso-Sandoval Tiffany; Lake Diana; D'Andrea Gabriella; Seidman Andrew; Sklarin Nancy; Dickler Maura; Currie Violante; Gilewski Theresa; Moynahan Mary Ellen; Drullinsky Pamela; Robson Mark; Wasserheit-Leiblich Carolyn; Mills Nancy; Steingart Richard; Panageas Katherine; Norton Larry; Hudis Clifford
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1216-22.
-
2008: Kauff Noah D; Domchek Susan M; Friebel Tara M; Robson Mark E; Lee Johanna; Garber Judy E; Isaacs Claudine; Evans D Gareth; Lynch Henry; Eeles Rosalind A; Neuhausen Susan L; Daly Mary B; Matloff Ellen; Blum Joanne L; Sabbatini Paul; Barakat Richard R; Hudis Clifford; Norton Larry; Offit Kenneth; Rebbeck Timothy R
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1331-7.
-
2007: Robson Mark E
Treatment of hereditary breast cancer.
Seminars in oncology 2007;34(5):384-91.
-
2007: King Tari A; Li Weiwei; Brogi Edi; Yee Cindy J; Gemignani Mary L; Olvera Narciso; Levine Douglas A; Norton Larry; Robson Mark E; Offit Kenneth; Borgen Patrick I; Boyd Jeff
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
Annals of surgical oncology 2007;14(9):2510-8.
-
2007: Smith Karen Lisa; Adank Muriel; Kauff Noah; Lafaro Kelly; Boyd Jeff; Lee Johanna B; Hudis Clifford; Offit Kenneth; Robson Mark
BRCA mutations in women with ductal carcinoma in situ.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4306-10.
-
2007: Robson Mark; Offit Kenneth
Clinical practice. Management of an inherited predisposition to breast cancer.
The New England journal of medicine 2007;357(2):154-62.
-
2007: Hurria Arti; Naeim Arash; Elkin Elena; Limaye Sewanti; Grover Anjali; Hudis Clifford; Pearce Carol; Robson Mark
Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Critical reviews in oncology/hematology 2007;61(3):255-60.
-
2007: Fornier Monica N; Seidman Andrew D; Lake Diana; D'Andrea Gabriella; Bromberg Jacqueline; Robson Mark; Van Poznak Catherine; Panageas Katherine S; Atienza Marietta; Norton Larry; Hudis Clifford
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):223-7.
-
2007: Robson Mark
Is breast conservation a reasonable option for women with BRCA-associated breast cancer?
Nature clinical practice. Oncology 2007;4(1):10-1.
-
2007: Lounsbury David W; Reynolds Thomas C; Rapkin Bruce D; Robson Mark E; Ostroff Jamie
Protecting the privacy of third-party information: recommendations for social and behavioral health researchers.
Social science & medicine (1982) 2007;64(1):213-22.
-
2006: Goldfrank Deborah; Chuai Shannon; Bernstein Jonine L; Ramon Y Cajal Teresa; Lee Johanna B; Alonso M Carmen; Diez Orland; Baiget Monserrat; Kauff Noah D; Offit Kenneth; Robson Mark
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(11):2311-3.
-
2006: Hurria Arti; Goldfarb Shari; Rosen Carol; Holland Jimmie; Zuckerman Enid; Lachs Mark S; Witmer Matthew; van Gorp Wilfred G; Fornier Monica; D'Andrea Gabriella; Moasser Mark; Dang Chau; Van Poznak Catherine; Robson Mark; Currie Violante E; Theodoulou Maria; Norton Larry; Hudis Clifford
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Breast cancer research and treatment 2006;98(3):343-8.
-
2006: Hurria Arti; Hurria Anju; Zuckerman Enid; Panageas Katherine S; Fornier Monica; D'Andrea Gabriella; Dang Chau; Moasser Mark; Robson Mark; Seidman Andrew; Currie Violante; VanPoznak Catherine; Theodoulou Maria; Lachs Mark S; Hudis Clifford
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Journal of the American Geriatrics Society 2006;54(7):1119-24.
-
2006: Smith Karen Lisa; Robson Mark E
Update on hereditary breast cancer.
Current oncology reports 2006;8(1):14-21.
-
2005: Kauff Noah D; Mitra Nandita; Robson Mark E; Hurley Karen E; Chuai Shaokun; Goldfrank Deborah; Wadsworth Eve; Lee Johanna; Cigler Tessa; Borgen Patrick I; Norton Larry; Barakat Richard R; Offit Kenneth
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Journal of the National Cancer Institute 2005;97(18):1382-4.
-
2005: Kauff Noah D; Hurley Karen E; Hensley Martee L; Robson Mark E; Lev Gali; Goldfrank Deborah; Castiel Mercedes; Brown Carol L; Ostroff Jamie S; Hann Lucy E; Offit Kenneth; Barakat Richard R
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.
Cancer 2005;104(2):314-20.
-
2005: Weitzel Jeffrey N; Robson Mark; Pasini Barbara; Manoukian Siranoush; Stoppa-Lyonnet Dominique; Lynch Henry T; McLennan Jane; Foulkes William D; Wagner Teresa; Tung Nadine; Ghadirian Parviz; Olopade Olufunmilayo; Isaacs Claudine; Kim-Sing Charmaine; Møller Pal; Neuhausen Susan L; Metcalfe Kelly; Sun Ping; Narod Steven A
A comparison of bilateral breast cancers in BRCA carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1534-8.
-
2005: Black Destin; Bogomolniy Faina; Robson Mark E; Offit Kenneth; Barakat Richard R; Boyd Jeff
Evaluation of germline PTEN mutations in endometrial cancer patients.
Gynecologic oncology 2005;96(1):21-4.
-
2005: Robson Mark; Svahn Tiffany; McCormick Beryl; Borgen Patrick; Hudis Clifford A; Norton Larry; Offit Kenneth
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
Cancer 2005;103(1):44-51.
-
2005: Siddiqui Rina; Onel Kenan; Facio Flavia; Nafa Kedoudja; Diaz Louis Robles; Kauff Noah; Huang Helen; Robson Mark; Ellis Nathan; Offit Kenneth
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
Familial cancer 2005;4(2):177-81.
-
2004: Robson Mark
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations.
Clinical breast cancer 2004;5(4):260-8; discussion 269-71.
-
2004: Satagopan J M; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach A D
A note on competing risks in survival data analysis.
British journal of cancer 2004;91(7):1229-35.
-
2004: Robson Mark E; Offit Kenneth
Breast MRI for women with hereditary cancer risk.
JAMA : the journal of the American Medical Association 2004;292(11):1368-70.
-
2004: Dang Chau T; D'Andrea Gabriella M; Moynahan Mary E; Dickler Maura N; Seidman Andrew D; Fornier Monica; Robson Mark E; Theodoulou Maria; Lake Diana; Currie Violante E; Hurria Arti; Panageas Katherine S; Norton Larry; Hudis Clifford A
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5754-61.
-
2004: King Tari A; Gemignani Mary L; Li Weiwei; Giri Dilip D; Panageas Kathy S; Bogomolniy Faina; Arroyo Crispinita; Olvera Narciso; Robson Mark E; Offit Kenneth; Borgen Patrick I; Boyd Jeff
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
Cancer research 2004;64(15):5051-3.
-
2004: Kirchhoff Tomas; Kauff Noah D; Mitra Nandita; Nafa Kedoudja; Huang Helen; Palmer Crystal; Gulati Tony; Wadsworth Eve; Donat Sheri; Robson Mark E; Ellis Nathan A; Offit Kenneth
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2918-21.
-
2004: Robson Mark E; Glogowski Emily; Sommer Gunhild; Antonescu Cristina R; Nafa Khedoudja; Maki Robert G; Ellis Nathan; Besmer Peter; Brennan Murray; Offit Kenneth
Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1250-4.
-
2004: Robles-Díaz Luis; Goldfrank Deborah J; Kauff Noah D; Robson Mark; Offit Kenneth
Hereditary ovarian cancer in Ashkenazi Jews.
Familial cancer 2004;3(3-4):259-64.
-
2004: Robson Mark E; Chappuis Pierre O; Satagopan Jaya; Wong Nora; Boyd Jeff; Goffin John R; Hudis Clifford; Roberge David; Norton Larry; Bégin Louis R; Offit Kenneth; Foulkes William D
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Breast cancer research : BCR 2004;6(1):R8-R17.
-
2003: Levine Douglas A; Argenta Peter A; Yee Cindy J; Marshall David S; Olvera Narciso; Bogomolniy Faina; Rahaman Jamal A; Robson Mark E; Offit Kenneth; Barakat Richard R; Soslow Robert A; Boyd Jeff
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4222-7.
-
2003: Brogi Edi; Robson Mark; Panageas Katherine S; Casadio Chiara; Ljung Britt-Marie; Montgomery Leslie
Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
Cancer 2003;98(10):2170-6.
-
2003: Offit Kenneth; Levran Orna; Mullaney Brian; Mah Katherine; Nafa Khedoudja; Batish Sat Dev; Diotti Raffaella; Schneider Hildegard; Deffenbaugh Amie; Scholl Thomas; Proud Virginia K; Robson Mark; Norton Larry; Ellis Nathan; Hanenberg Helmut; Auerbach Arleen D
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
Journal of the National Cancer Institute 2003;95(20):1548-51.
-
2003: Morris Elizabeth A; Liberman Laura; Ballon Douglas J; Robson Mark; Abramson Andrea F; Heerdt Alexandra; Dershaw D David
MRI of occult breast carcinoma in a high-risk population.
AJR. American journal of roentgenology 2003;181(3):619-26.
-
2003: Antonescu Cristina R; Sommer Gunhild; Sarran Lisa; Tschernyavsky Sylvia J; Riedel Elyn; Woodruff James M; Robson Mark; Maki Robert; Brennan Murray F; Ladanyi Marc; DeMatteo Ronald P; Besmer Peter
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3329-37.
-
2003: Hensley Martee L; Robson Mark E; Kauff Noah D; Korytowsky Beata; Castiel Mercedes; Ostroff Jamie; Hurley Karen; Hann Lucy E; Colon Jasmine; Spriggs David
Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
Gynecologic oncology 2003;89(3):440-6.
-
2003: Robson Mark; Hensley Martee; Barakat Richard; Brown Carol; Chi Dennis; Poynor Elizabeth; Offit Kenneth
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Gynecologic oncology 2003;89(2):281-7.
-
2003: Kauff Noah D; Brogi Edi; Scheuer Lauren; Pathak Dorothy R; Borgen Patrick I; Hudis Clifford A; Offit Kenneth; Robson Mark E
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
Cancer 2003;97(7):1601-8.
-
2003: Offit Kenneth; Pierce Heather; Kirchhoff Tomas; Kolachana Prema; Rapaport Beth; Gregersen Peter; Johnson Steven; Yossepowitch Orit; Huang Helen; Satagopan Jaya; Robson Mark; Scheuer Lauren; Nafa Khedoudja; Ellis Nathan
Frequency of CHEK2*1100delC in New York breast cancer cases and controls.
BMC medical genetics 2003;4():1.
-
2002: Offit Kenneth; Gilad Shlomit; Paglin Shoshana; Kolachana Prema; Roisman Laila C; Nafa Khedoudja; Yeugelewitz Vincent; Gonzales Maria; Robson Mark; McDermott Deborah; Pierce Heather Hanson; Kauff Noah D; Einat Paz; Jhanwar Suresh; Satagopan Jaya M; Oddoux Carole; Ellis Nathan; Skaliter Rami; Yahalom Joachim
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3813-9.
-
2002: Satagopan Jaya M; Boyd Jeff; Kauff Noah D; Robson Mark; Scheuer Lauren; Narod Steven; Offit Kenneth
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3776-81.
-
2002: Narod Steven A; Dubé Marie-Pierre; Klijn Jan; Lubinski Jan; Lynch Henry T; Ghadirian Parviz; Provencher Diane; Heimdal Ketil; Moller Pal; Robson Mark; Offit Kenneth; Isaacs Claudine; Weber Barbara; Friedman Eitan; Gershoni-Baruch Ruth; Rennert Gad; Pasini Barbara; Wagner Theresa; Daly Mary; Garber Judy E; Neuhausen Susan L; Ainsworth Peter; Olsson Hakan; Evans Gareth; Osborne Michael; Couch Fergus; Foulkes William D; Warner Ellen; Kim-Sing Charmaine; Olopade Olufunmilayo; Tung Nadine; Saal Howard M; Weitzel Jeffrey; Merajver Sofia; Gauthier-Villars Marion; Jernstrom Helena; Sun Ping; Brunet Jean-Sebastien
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2002;94(23):1773-9.
-
2002: Robson Mark E
Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
Cancer control : journal of the Moffitt Cancer Center 2002;9(6):457-65.
-
2002: Robson M
Tamoxifen for primary breast cancer prevention in BRCA heterozygotes.
European journal of cancer (Oxford, England : 1990) 2002;38 Suppl 6():S18-9.
-
2002: Robson Mark E; Offit Kenneth
Considerations in genetic counseling for inherited breast cancer predisposition.
Seminars in radiation oncology 2002;12(4):362-70.
-
2002: Archey William B; McEachern Kristen A; Robson Mark; Offit Kenneth; Vaziri Susan A J; Casey Graham; Borg Ake; Arrick Bradley A
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Oncogene 2002;21(46):7034-41.
-
2002: Kauff N D; Perez-Segura P; Robson M E; Scheuer L; Siegel B; Schluger A; Rapaport B; Frank T S; Nafa K; Ellis N A; Parmigiani G; Offit K
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.
Journal of medical genetics 2002;39(8):611-4.
-
2002: Kauff Noah D; Satagopan Jaya M; Robson Mark E; Scheuer Lauren; Hensley Martee; Hudis Clifford A; Ellis Nathan A; Boyd Jeff; Borgen Patrick I; Barakat Richard R; Norton Larry; Castiel Mercedes; Nafa Khedoudja; Offit Kenneth
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
The New England journal of medicine 2002;346(21):1609-15.
-
2002: Scheuer Lauren; Kauff Noah; Robson Mark; Kelly Bridget; Barakat Richard; Satagopan Jaya; Ellis Nathan; Hensley Martee; Boyd Jeff; Borgen Patrick; Norton Larry; Offit Kenneth
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1260-8.
-
2002: Robson M; Scheuer L; Nafa K; Ellis N; Offit K
Unique de novo mutation of BRCA2 in a woman with early onset breast cancer.
Journal of medical genetics 2002;39(2):126-8.
-
2001: Offit K; Robson M; Schrag D
Prophylactic mastectomy in carriers of BRCA mutations.
The New England journal of medicine 2001;345(20):1498-9; author reply 1499-500.
-
2001: Kauff N D; Scheuer L; Robson M E; Glogowski E; Kelly B; Barakat R; Heerdt A; Borgen P I; Davis J G; Offit K
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.
Genetics in medicine : official journal of the American College of Medical Genetics 2001;3(6):422-5.
-
2001: Robson M E; Boyd J; Borgen P I; Cody H S
Hereditary breast cancer.
Current problems in surgery 2001;38(6):387-480.
-
2001: Satagopan J M; Offit K; Foulkes W; Robson M E; Wacholder S; Eng C M; Karp S E; Begg C B
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(5):467-73.
-
2001: Levine D A; Lin O; Barakat R R; Robson M E; McDermott D; Cohen L; Satagopan J; Offit K; Boyd J
Risk of endometrial carcinoma associated with BRCA mutation.
Gynecologic oncology 2001;80(3):395-8.
-
2000: Narod S A; Brunet J S; Ghadirian P; Robson M; Heimdal K; Neuhausen S L; Stoppa-Lyonnet D; Lerman C; Pasini B; de los Rios P; Weber B; Lynch H;
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Lancet 2000;356(9245):1876-81.
-
2000: Hensley M L; Castiel M; Robson M E
Screening for ovarian cancer: what we know, what we need to know.
Oncology (Williston Park, N.Y.) 2000;14(11):1601-7; discussion 1608, 1613-6.
-
2000: Robson M
Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21 Suppl):113S-8S.
-
2000: Barakat R R; Federici M G; Saigo P E; Robson M E; Offit K; Boyd J
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.
Cancer 2000;89(2):383-90.
-
1999: Robson M; Levin D; Federici M; Satagopan J; Bogolminy F; Heerdt A; Borgen P; McCormick B; Hudis C; Norton L; Boyd J; Offit K
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
Journal of the National Cancer Institute 1999;91(24):2112-7.
-
1999: Hill A; Yagmur Y; Tran K N; Bolton J S; Robson M; Borgen P I
Localized male breast carcinoma and family history. An analysis of 142 patients.
Cancer 1999;86(5):821-5.
-
1998: Rhei E; Bogomolniy F; Federici M G; Maresco D L; Offit K; Robson M E; Saigo P E; Boyd J
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
Cancer research 1998;58(15):3193-6.
-
1998: Frank T S; Manley S A; Olopade O I; Cummings S; Garber J E; Bernhardt B; Antman K; Russo D; Wood M E; Mullineau L; Isaacs C; Peshkin B; Buys S; Venne V; Rowley P T; Loader S; Offit K; Robson M; Hampel H; Brener D; Winer E P; Clark S; Weber B; Strong L C; Thomas A
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2417-25.
-
1998: Robson M; Gilewski T; Haas B; Levin D; Borgen P; Rajan P; Hirschaut Y; Pressman P; Rosen P P; Lesser M L; Norton L; Offit K
BRCA-associated breast cancer in young women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1642-9.
-
1998: Robson M; Rajan P; Rosen P P; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K
BRCA-associated breast cancer: absence of a characteristic immunophenotype.
Cancer research 1998;58(9):1839-42.
-
1997: Robson M E; Offit K
New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer.
Lancet 1997;350(9071):117-8.
-
1997: Robson M; Dabney M K; Rosenthal G; Ludwig S; Seltzer M H; Gilewski T; Haas B; Osborne M; Norton L; Gilbert F; Offit K
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
Genetic testing 1997;1(1):47-51.
-
1996: McBride C E; Yavorski R T; Moses F M; Robson M E; Solimando D A; Byrd J C
Acute pancreatitis associated with continuous infusion cytarabine therapy: a case report.
Cancer 1996;77(12):2588-91.
-
1993: Grem J L; Jordan E; Robson M E; Binder R A; Hamilton J M; Steinberg S M; Arbuck S G; Beveridge R A; Kales A N; Miller J A
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1737-45.
Sign-in to see more